Acadia Healthcare has expanded its network of Comprehensive Treatment Centers (CTCs), reaching 170 locations across 33 states that provide specialized care for opioid use disorder. This expansion represents a component of the company’s approach to addressing the ongoing substance abuse crisis affecting communities nationwide, particularly in areas where access to addiction treatment remains limited.
The CTC network now serves approximately 74,000 patients daily, providing medication-assisted treatment combined with behavioral therapy and counseling services. This integrated approach has proven effective in helping patients achieve recovery from opioid addiction, with outcomes that exceed national averages for similar treatment programs.
Network Growth Addresses Treatment Gaps
Acadia Healthcare added seven new comprehensive treatment centers during the first quarter of 2025, demonstrating continued commitment to expanding access in communities where opioid use disorder treatment options remain limited. The expansion from 163 centers to 170 locations reflects both organic growth and targeted development in markets with demonstrated need for specialized services.
The company’s CTC network accepts patients with Medicaid coverage alongside other insurance options, ensuring treatment accessibility for diverse patient populations. This approach addresses financial barriers that often prevent individuals from accessing needed addiction treatment services, particularly in rural and economically disadvantaged communities where Acadia Healthcare has focused expansion efforts.
Evidence-Based Treatment Approach
The comprehensive treatment model employed across Acadia Healthcare’s CTC network combines medication-assisted treatment protocols with behavioral therapy programs, individual and group counseling services, and approaches that address both medical and psychological aspects of addiction recovery. This integrated methodology recognizes that addiction treatment requires addressing multiple dimensions of patient needs.
Medication-assisted treatment forms the clinical foundation of CTC services, utilizing FDA-approved medications to reduce withdrawal symptoms and cravings while patients engage in therapeutic programming. The combination of pharmacological intervention with behavioral health services has demonstrated outcomes compared to either approach used independently.
Clinical Outcomes Exceed Industry Standards
Acadia Healthcare’s CTC network achieves clinical outcomes, with 80% of patients reaching opioid-free status within six months of treatment initiation. This performance exceeds the 45% national average for similar treatment programs, demonstrating the effectiveness of the company’s integrated care model and expertise in addiction medicine.
Patient retention and satisfaction metrics further validate the CTC approach, with patients remaining engaged in treatment programs at rates that support long-term recovery success. The company’s evidence-based treatment protocols and comprehensive support services contribute to these outcomes across diverse patient populations and geographic markets.
Market Impact and Future Growth
The CTC business is projected to experience mid-single-digit growth rates over the next several years, reflecting both market demand for opioid use disorder treatment and Acadia Healthcare’s continued expansion into underserved communities. The company’s focus on both urban and rural markets addresses geographic disparities in addiction treatment access that have historically left many communities without adequate resources.
Acadia Healthcare’s comprehensive treatment centers serve as community resources for addiction recovery services, often providing specialized care in regions where such services were previously unavailable. The network’s continued growth supports broader public health objectives while addressing healthcare challenges facing communities across the United States.
Comments are closed.